Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views
- PMID: 27355576
- PMCID: PMC4927112
- DOI: 10.1371/journal.pone.0158365
Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views
Abstract
Background: Only a minority of patients at high risk for osteoporotic fracture receive treatment.
Objective: Study patients' and physicians' views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care.
Methods: A qualitative study involving 18 physicians and 37 women (age 57-87) with PMO.
Results: All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age. The women identified a large number of "causes" for osteoporosis but finally viewed it as chance. They all described its progression as slow. Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5). These representations did not appear linked to age or fracture. Even the women who associated fracture and PMO were uncertain of the link between them. Fractures were considered to be random events, independent of osteoporosis. Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis. Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance. As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO. However, some considered the impact of fractures to be limited in time, and viewed PMO as a "benign" disease. Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases. Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance.
Conclusion: Women's and physicians' perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease. A better understanding of women's and physicians' views, practices, and concerns related to PMO can improve osteoporosis management.
Conflict of interest statement
Similar articles
-
Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.Osteoporos Int. 2019 Jan;30(1):177-185. doi: 10.1007/s00198-018-4720-5. Epub 2018 Oct 10. Osteoporos Int. 2019. PMID: 30306220
-
Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.Drugs Aging. 2007;24(7):603-14. doi: 10.2165/00002512-200724070-00007. Drugs Aging. 2007. PMID: 17658910
-
Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study.Osteoporos Int. 2013 Dec;24(12):3001-10. doi: 10.1007/s00198-013-2408-4. Epub 2013 Jun 11. Osteoporos Int. 2013. PMID: 23754200 Free PMC article.
-
Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause.Expert Opin Pharmacother. 2024 Jul;25(10):1359-1372. doi: 10.1080/14656566.2024.2383639. Epub 2024 Jul 27. Expert Opin Pharmacother. 2024. PMID: 39039930 Review.
-
Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.Curr Med Res Opin. 2013 Mar;29(3):205-16. doi: 10.1185/03007995.2013.763779. Epub 2013 Jan 25. Curr Med Res Opin. 2013. PMID: 23297819 Review.
Cited by
-
Alendronate promotes osteoblast differentiation and bone formation in ovariectomy-induced osteoporosis through interferon-β/signal transducer and activator of transcription 1 pathway.Exp Ther Med. 2018 Jan;15(1):182-190. doi: 10.3892/etm.2017.5381. Epub 2017 Oct 27. Exp Ther Med. 2018. PMID: 29375681 Free PMC article.
-
Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.J Bone Miner Res. 2018 May;33(5):763-772. doi: 10.1002/jbmr.3395. Epub 2018 Feb 26. J Bone Miner Res. 2018. PMID: 29377378 Free PMC article. Clinical Trial.
-
Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.Osteoporos Int. 2021 Dec;32(12):2473-2484. doi: 10.1007/s00198-021-05951-1. Epub 2021 Jun 7. Osteoporos Int. 2021. PMID: 34095966 Free PMC article.
-
Fracture liaison service-a multidisciplinary approach to osteoporosis management.Osteoporos Int. 2024 Oct;35(10):1719-1727. doi: 10.1007/s00198-024-07181-7. Epub 2024 Jul 18. Osteoporos Int. 2024. PMID: 39020092 Free PMC article. Review.
-
Exercise Prescription and the Minimum Dose for Bone Remodeling Needed to Prevent Osteoporosis in Postmenopausal Women: A Systematic Review.Cureus. 2022 Jun 16;14(6):e25993. doi: 10.7759/cureus.25993. eCollection 2022 Jun. Cureus. 2022. PMID: 35859964 Free PMC article. Review.
References
-
- Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006;35: 293–305. - PubMed
-
- National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis Washington, DC: National Osteoporosis Foundation; 2014. Available: http://nof.org/files/nof/public/content/file/2791/upload/919.pdf. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials